ENTA 股东权益历史(2016–2025)
ENANTA PHARMACEUTICALS INC (ENTA) 各财年年末股东权益(来自 SEC 财报)。
$64.7MFY2025 · FY2016 以来:$269.9M → $64.7M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $64.7M | -49.8% |
| FY2024 | $128.8M | -40.6% |
| FY2023 | $216.7M | -32.6% |
| FY2022 | $321.3M | -19.6% |
| FY2021 | $399.4M | -12.3% |
| FY2020 | $455.6M | -1.5% |
| FY2019 | $462.5M | +17.5% |
| FY2018 | $393.7M | +30.5% |
| FY2017 | $301.7M | +11.8% |
| FY2016 | $269.9M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议